Shots:
- Roche has reported CE Mark approval of its Elecsys Dengue Ag test to aid in the diagnosis of an acute dengue virus infection
- The Elecsys Dengue Ag is an in-vitro immunoassay for qualitative detection of the dengue virus NS1 antigen in human serum & plasma, designed for use on Roche’s cobas e 801 & cobas e 402 automated analyzers
- Elecsys Dengue Ag detects NS1 antigen across all 4 dengue serotypes (DENV-1, DENV-2, DENV-3 & DENV-4), showing 94.9% sensitivity in PCR-confirmed positives & 99.96% relative specificity in healthy donor samples in clinical studies
Ref: Roche | Image: Roche | Press Release
Related News:- Roche Reports P-III (INShore) Trial Findings on Gazyva (Obinutuzumab) for Idiopathic Nephrotic Syndrome
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
